DEC 18, 2018 01:34 PM PST

Researchers Discover New Strains of Hepatitis C

WRITTEN BY: Carmen Leitch

Scientists studying hepatitis C have identified three new strains of the virus in the most extensive population study of the infection that's ever been done in Africa. The international team that produced the data has suggested that current antiviral drugs used to treat hepatitis C in the West might not work against these new strains; clinical trials should be performed immediately to assess treatment strategies and find the best ones for patients in sub-Saharan Africa. The findings have been reported in Hepatology, and should be considered as the World Health Organization attempts to eradicate hepatitis C.

"In the largest study of hepatitis C in the general population in sub-Saharan Africa to date, we found a diverse range of hepatitis C virus strains circulating, and also discovered new strains that had never been seen before. Further research is needed as some antiviral drugs are effective against specific strains of hepatitis C virus and may not work as well in these populations,” said the study’s co-first author Dr. George S. Mgomella.

Infection with the hepatitis C virus (HCV) can cause hepatitis C, a disease of the liver. It can lead to cirrhosis - chronic damage in the liver, and liver failure. It’s transmitted primarily through exposure to contaminated blood, mainly by needles. It’s estimated that 71 million people have hepatitis C, many of whom live in sub-Saharan Africa. There is no cure or vaccine, and about 400,000 die from the disease annually. The World Health Organization announced in 2016 that it would make eliminating hepatitis C a priority; they want to meet that goal by 2030. 

While the Western world has access to antiviral drugs that are effective against several strains of HCV, research on the hepatitis C strains circulating in poor parts of the world, including sub-Saharan Africa, has been extremely limited. Not all infected people have been diagnosed, those that have been infected are not always treated, and public health officials don’t know much about which strains are common and where. 

"It is important that there is a concerted effort to characterize hepatitis C strains in sub-Saharan Africa at a population level in order to assist countries to select optimal treatments for national procurement,” said senior author Dr. Emma Thomson of Glasgow University. “It will also be important to inform vaccine design which would catalyze the elimination of hepatitis C by 2030."

For this work, careful screening was done on 7,751 blood samples collected from individuals in the general population in Uganda. The researchers identified HCV that had not been diagnosed yet in twenty people. The team sequenced the genomes from those twenty samples as well as two from the Democratic Republic of Congo (DRC). They found three previously unknown HCV strains as well as some that are common in the Westen world. They also found mutations that are associated with drug resistance in some of those samples.

The researchers concluded that screening methods used in Uganda, which rely on antibody detection, are inaccurate. A better method is to look for the virus itself. Because the virus may be gaining resistance to antiviral drugs, new treatment approaches may also be needed.

"Our study highlights the need for more investment on people in Africa and developing parts of the world. We show there are clear differences in HCV across the world, underlining the need for understanding HCV globally. Our work will help inform public health policy and reveals that further studies and clinical trials in sub-Saharan Africa are urgently needed if the WHO is to achieve its vision of eliminating hepatitis C by 2030,” said one of the senior authors of the work, Dr. Manj Sandhu. 


Sources: AAAS/Eurekalert! via Wellcome Trust Sanger Institute, Hepatology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 20, 2019
Microbiology
JAN 20, 2019
A Mosquito Repellent - Made by Bacteria
Beneficial microbes are already a source of antibiotics. Now researchers have found a microbial mosquito repellent...
JAN 27, 2019
Microbiology
JAN 27, 2019
Alzheimer's Linked to a Gum Disease-associated Bacterium
Alzheimer's is more likely in the aged, but the exact causes were unclear. New work shows that it may stem from a brain infection....
FEB 10, 2019
Cell & Molecular Biology
FEB 10, 2019
Anti-CRISPR Proteins Appear to be Naturally Abundant
Proteins that can counteract the CRISPR system appear to be more common than thought....
FEB 27, 2019
Immunology
FEB 27, 2019
When the Cell Dials 9-1-1
Researchers can now explain how a cell that is being attacked by bacteria or viruses specifically manages to 'sound the alarm'...
MAR 07, 2019
Microbiology
MAR 07, 2019
Mathematicians Describe Microbial Movement
Swarming behavior has been observed throughout biology; cells, insects, and birds, for example, have all been observed exhibiting the behavior....
MAR 15, 2019
Health & Medicine
MAR 15, 2019
Tick-Borne Diseases Are Rapidly Rising in the U.S.
Tick-borne diseases have significantly increased in the U.S. in the past few years. In 2016 there were 48,610 reported cases and in 2017 59,349; these...
Loading Comments...